BioCentury
ARTICLE | Clinical News

Masican masitinib: Phase III ongoing

February 16, 2015 8:00 AM UTC

AB Science said an IDMC recommended continuation of the double-blind, placebo-controlled, international Phase III AB09004 trial of once-daily oral masitinib based on a futility analysis performed afte...